Partnering to Transform Cancer Research
From highly prevalent to rare cancers, our oncology CRO services deliver agile, patient‑first solutions that drive recruitment, prioritize safety, and build a strong foundation for trial success.
Navigating Complexity with Confidence
Through strong local relationships and extensive site and investigator alliances, we connect you to diverse patient pools across cancer types, including breast, lung, and rare cancers.
By building trust and engagement through site alliances, we accelerate screening and enrollment with exceptional reach and effectiveness in the APAC region and beyond.
We grow with you through in‑depth recruitment and retention plans and a flexible approach, enabling seamless expansion to additional sites as your trial evolves.
With extensive research and regulatory experience, advanced operational solutions, and renowned scientific leadership, you can trust us to deliver your trial with excellence.
Our global reach includes sites with the infrastructure for first‑in‑human and first‑in‑patient trials, later‑phase studies, and post‑marketing surveillance.
Specialized CRO Services Across Cancer Types
Breast
105+ studies
Lung
68+ studies
Genitourinary
70+ studies
Gastrointestinal
35+ studies
Hematological
66+ studies
Other Cancer Types
400+ total studies
Strategic Leadership in Action
Rachel Condjella Ph.D.
Dr. Condjella has over 18 years of oncology experience and over 6 years in clinical project management. She has managed projects from inception and development to operational initiation through closeout. Her therapeutic areas of expertise include implementation and management of basket/umbrella trials, first‑in‑human trials, precision medicine for targeted treatments, breast cancer, bladder cancer, cholangiocarcinoma, pancreatic cancer, and other GI cancers, acute myeloid leukemia, and myeloproliferative disorders. She has authored publications contributing to the identification of new therapeutic and diagnostic options for cancer patients and participated in the creation and presentation of data at international conferences.
Oncology CRO Expertise Without Limits
We’re the CRO that turns challenges into opportunities through proactive operational risk management and mitigation plans.
Our impact-driven teams prioritize timely, on-budget delivery while consistently producing top-tier datasets and maintaining uncompromising quality.
From regulatory hurdles to specialized recruitment strategies and novel therapies, we support even the most advanced oncology studies, including cell and gene therapy (CGT) trials.
With a global team and expertise across diverse therapeutic areas, we help you overcome challenges and advance clinical research.
Our areas of expertiseMeet our team
Oncology CRO Services, Your Way
With global reach, local teams, and industry‑leading experts, we deliver exceptional oncology CRO services at every stage of your trial—as individual offerings or comprehensive solutions.
Patient Recruitment
Accelerate recruitment through our global alliances with trusted sites, including a strong APAC presence.
Regulatory Consulting
Drive efficient approvals with a fully compliant regulatory strategy tailored to your trial.
Study Design & Start‑Up
Develop custom, cost‑effective programs and protocols for projects of any complexity.
Clinical Trial Monitoring
Ensure patient safety, data integrity, and trial success through local expertise and oversight.
Frequently asked questions
What types of oncology trials can you support?
We support oncology trials across every phase, from first‑in‑human studies to post‑marketing pharmacovigilance. With world‑leading early‑phase capabilities in Australia, including a 3.5‑month Phase I start‑up timeline and purpose‑built facilities, we deliver exceptional support throughout the trial lifecycle.
Our industry‑leading oncology expertise spans a broad range of cancer types, from breast and lung tumors to sarcomas and hematological malignancies. Request a proposal to find out how we can help you.
Can you support multi‑national or global oncology trials?
Absolutely. We have a strong worldwide presence with on‑the‑ground teams in 40+ global locations, including the APAC region. Our established alliances with dedicated investigators and sites underpin our exceptional recruitment and retention rates across diverse patient populations. Local experts ensure cultural sensitivity and streamlined communication across all oncology CRO services.
What steps do you take to ensure compliance with evolving regulations?
We monitor regulatory changes globally and adapt strategies to maintain compliance. Our dedicated team stays updated on evolving standards, liaises with local authorities, and proactively adjusts documentation, processes, and timelines so you can be confident that your trial aligns with the latest requirements in every region. Visit Regulatory Consulting for more information.
What other therapeutic areas do you support?
We bring deep expertise across a wide range of therapeutic areas, from neurology and respiratory diseases to endocrinology and medical devices, with specialized leadership in renal, cardiometabolic, and oncology trials. We’re your partner in advancing impactful therapies that transform lives worldwide, delivering innovative, patient‑focused solutions. Visit Therapeutic Expertise for more information.
Oncology Impact & Insights
Access the latest insights from oncology conferences and dive into case studies to see how we deliver real‑world impact through innovative oncology CRO services.
Driving Pancreatic Cancer Progress
Discover how we saved a trial from closure through regulatory expertise and exceptional operational efficiency.
ASCO 2024: Focusing on Comfort and Cures
Explore recent advancements, the impact of AI in oncology research, and patient wellbeing‑centered care.
Supporting Pioneering Oncology Research
See how we drove a novel oncology trial forward through end‑to‑end services and local expertise.
Patient‑First Design Drives Phase I Success
Read how our established site alliances and flexible approach ensured smooth trial delivery in Australia.